Medical Oddities: Friends, Family… and Faster Aging?
-
By
-
Teraya Smith
-
March 18, 2026
-
6 min
By
Teraya Smith
March 18, 2026
In VIKTORIA-1, gedatolisib-containing regimens resulted in longer median progression-free survival than fulvestrant alone.
July 14, 2026
The approval expands subcutaneous use across newly diagnosed and previously treated multiple myeloma.
July 10, 2026
Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.
July 2, 2026